• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMB

INTELLIGENT MONITORING GROUP LIMITED - News & Media

3.17% ! 61.0¢
Market Cap $216.6M  !
Industrials Security & Protection Services
Add to My Watchlist

Intelligent Monitoring Group Limited is an Australia-based security company. The Company... Intelligent Monitoring Group Limited is an Australia-based security company. The Company is engaged in providing provision of security, monitoring and risk management services in Australia. The Company operates through three segments: Monitoring, Protective services and Service. Its Monitoring segment provides security alarm and video monitoring. Its Protective services segment provides security guarding and personnel services. Its Service segment provides alarm and video installation and maintenance services. The Company’s personal solutions include monitored security systems, intruder detection, safe at home, safe haven, high net worth family security and security response. The Company’s business solutions include business security, security and risk consultancy, monitored security systems, security personnel and case studies.More

No News & Media currently available.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
61.0¢ 		Change
-0.020(3.17%) 		Mkt cap ! $216.6M
Open High Low Value Volume
63.0¢ 63.0¢ 60.0¢ $303.9K 492.4K

Buyers (Bids)

No. Vol. Price($)
1 1200 60.5¢
 

Sellers (Offers)

Price($) Vol. No.
61.0¢ 16142 1
View Market Depth
Last trade - 16.10pm 22/05/2025 (20 minute delay) ?
Last
60.5¢ 		  Change
-0.020 ( 4.47 %)
Open High Low Volume
63.0¢ 63.0¢ 60.0¢ 103978
Last updated 15.59pm 22/05/2025 ?
IMB (ASX) Chart

Top Stories

Mayne Pharma nosedive deepens as Cosette mulls scrapping $672M buy-up

Mayne Pharma Group (ASX:MYX) has been taking a beating in the markets this week, with company value as much as -33% lower @ today down to $4.34 a share after opening Week 21 at $6.48 @ on second thoughts from Cosette.Listen to the HotCopper podcast for in-depth discussions and insights on all the...
Raiden snaps up 75% of Vuzel gold project in Bulgaria as lithium days put to rest Raiden Resources (ASX:RDN) has all but formally pivoted away from lithium with its move to 75% ownership of the Vuzel gold...
Long dormant Provaris, building a hydrogen tanker, eyes new market: CO2 storage Provaris Ltd (ASX:PV1), a decidedly unique ASX stock – it's attempting to build a world first hydrogen storage shipping tanker – has made...
An RBA cut was locked in. Beijing’s identical Tuesday cut spotlights larger macro forces An RBA cut was basically guaranteed. But Beijing’s identical Tuesday move spotlights larger macro forces After seeing countries...
This stock could have something close to a cure for osteoarthritis. Don’t let it hide under your nose Paradigm Biopharmaceuticals (ASX:PAR) is a late-stage drug development company working first and foremost to create a superior treatment for osteoarthritis.In the background, Paradigm also has a rare disease clinal asset for Mucopolysaccharidosis (MPS) and early-stage data for acute respiratory d...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.